Healthcare

This issue of Vital Signs, released on September 28, 2012, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.

The key objective of this research service  is to study the European Alzheimers disease medication market based on the three major classes of drugs namely acetylcholinesterase inhibitors, NMDA receptor antagonists and new mechanism/ disease modifying drugs and identify the key current and future trends shaping these market segments.  It also aims...

Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. This customer research was completed to understand trends, dynamics, and parameters specific to the delivery of drugs to cancer patients; identify physicians prescribing trends relative to delivery considerations; understand the role of reimburs...

The clinical capabilities of interventional radiology (IR) have developed faster than any other area of medicine. Along with parallel technology evolution in computer technology, medical physics and developments in endovascular catheter technology, interventional radiologists are slowing replacing major open surgeries with minimally invasive and le...

This issue of Vital Signs, released on September 26, 2012, provides an insight in to the research antibodies market place. The survey captures the purchasing, budget, application, and technology trends of research antibody use. Additionally, the survey determines customer ratings of suppliers, supplier usage, unmet needs, and challenges.

The following market insight provides a review of four companies' approaches to adding value to the molecular diagnostics market. These vendors employed one of four strategies: lowing the cost of molecular diagnostics manufacturing, improving upon the molecular diagnostics sample preparation process, combining established molecular diagnostic techn...

The following market insight provides an overview of the current state of the advanced visualization market in the U.S., evaluating the current adoption of enterprise solutions replacing conventional stand-alone solutions. It also provides an analysis of the competitive dynamics shaping up the advanced visualization industry in the U.S., in light o...

Indonesia, one of the largest markets for healthcare in Southeast Asia, has participants from both the public and private sectors. In order to boost the medical services in the country, the Government is encouraging private investors, including foreign companies, to play a more active role in the healthcare industry. It has increased the foreign di...

This research service presents an overview of the South Korean biosimilars market and analyzes the opportunities that lay ahead for different stakeholders in the development, manufacturing, and commercialization of biosimilars. This service divides the market into therapeutic proteins and monoclonal antibodies. Further, it aims to present an overvi...